Skip to main content
Category

NASDAQ

BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy NASDAQ

BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy

BioNexus Gene Lab (BGLC) has adopted an Ethereum-focused treasury strategy, thus becoming the first Nasdaq-listed company to prioritize ETH. The exact percentage for its Ethereum allocation has not been divulged by the company but the move follows the leading altcoin’s inclusion in the US “Crypto Strategic Reserve.” BGLC Embraces Ethereum…
bubmag
May 5, 2025
Nasdaq-listed video-sharing platform Rumble invests $17.1M in Bitcoin (BTC) NASDAQ

Nasdaq-listed video-sharing platform Rumble invests $17.1M in Bitcoin (BTC)

Rumble bought 188 Bitcoin (BTC) for $17.1M, nearing its $20M goal. Rumble’s CEO sees BTC as an inflation hedge and crypto tie-in. Future Rumble BTC purchases depend on market and cash flow conditions. Rumble, a Nasdaq-listed video-sharing platform and cloud services provider trading under the ticker RUM, has purchased $17.1…
bubmag
March 12, 2025
Stocks Finish Lower on US Tariff Hike on Canadian Steel and Aluminum NASDAQ

Stocks Finish Lower on US Tariff Hike on Canadian Steel and Aluminum

The S&P 500 Index ($SPX) (SPY) Tuesday closed down -0.76%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -1.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.28%.  March E-mini S&P futures (ESH25) are down -0.76%, and March E-mini Nasdaq futures (NQH25) are down -0.26%.  Stock indexes Tuesday added to Monday’s sharp…
bubmag
March 12, 2025
Sun Pharma shares in focus as co announces plan to acquire Checkpoint Therapeutics for $355 million NASDAQ

Sun Pharma shares in focus as co announces plan to acquire Checkpoint Therapeutics for $355 million

Continue reading with one of these options: Limited Access Free Login to get access to some exclusive stories & personalised newsletters Login Now Unlimited Access Starting @ Rs120/month Get access to exclusive stories, expert opinions & in-depth stock reports Subscribe Now Uh-oh! This is an exclusive story available for selected…
bubmag
March 10, 2025